Neuren Pharmaceuticals | NEU - Assets

Stock Price
11.48
Daily Change
0.08 0.70%
Monthly
-12.23%
Yearly
-6.36%
Q1 Forecast
11.51

Neuren Pharmaceuticals reported AUD342.86M in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Akebia Therapeutics USD 376.56M 12.41M Dec/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Avita Medical AUD 56.39M 1.74M Dec/2025
Clinuvel Pharmaceuticals AUD 231.12M 19.44M Jun/2024
Dianthus Therapeutics USD 530.92M 46.52M Dec/2025
Genetic Signatures AUD 49.04M 5.59M Dec/2025
Ionis Pharmaceuticals USD 3.52B 490.91M Dec/2025
Medical Developments International AUD 63.57M 2.83M Dec/2025
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
Organon & Co USD 13.55B 52M Sep/2025
Paradigm Biopharmaceuticals AUD 24.57M 10.79M Jun/2025
PYC Therapeutics AUD 159.13M 24.15M Dec/2025
Starpharma Holdings AUD 26.17M 746K Dec/2025
Tectonic Therapeutic USD 277M 18.31M Sep/2025
Telix Pharmaceuticals AUD 1.16B 25.97M Dec/2025
Viatris USD 37.19B 727.3M Dec/2025
Xeris Pharmaceuticals USD 370.19M 35.5M Sep/2025